National Osteoporosis Guidelines Group (NOGG) UK – Summary of Main Recommendations
Updated September 2024 This summary addresses the assessment, diagnosis and current treatments for osteoporosis, including recommendations to prevent fragility fractures. It applies to postmenopausal women, and to men age 50 years or older. Concerning assessment of fracture risk in postmenopausal women, and men age ≥50: Regarding drug treatment to prevent fractures in postmenopausal women, and…
2019 EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
Algorithm of glandular function assessment and therapeutic approach in patients with primary SjS presenting with oral dryness. SjS, Sjögren syndrome; SWSF, stimulated whole salivary flows; UWSF, unstimulated whole salivary flows. Algorithm of glandular function assessment and therapeutic approach in patients with primary SjS presenting with ocular dryness. *Consider neuropathic pain if OSS≤1. **Additional criteria for…
Overarching Principles and Recommendations in the Management of Gout
Overarching Principles A Every person with gout should be fully informed about the pathophysiology of the disease, the existence of effective treatments, associated comorbidities and the principles of managing acute attacks and eliminating urate crystals through lifelong lowering of SUA level below a target level. B Every person with gout should receive advice regarding lifestyle:…
2016 Updated EULAR Recommendations for Management of flares in patients with Gout
Management of acute flare according to the European League Against Rheumatism recommendations. Letters and numbers in parentheses indicate the items of the recommendations presented in the table. Strong P-glycoprotein or CYP3A4 inhibitors are cyclosporin, clarithromycin, ketoconazole and ritonavir. IL, interleukin; NSAID, non-steroidal anti-inflammatory drug; PPI, proton pump inhibitor; ULT, urate-lowering therapy.
Overarching principles for treatment of Systemic Lupus Erythematosus
A. SLE requires multidisciplinary, individualised management with patient education and shared decision- making, taking into consideration the costs to patient and society B. SLE disease activity should be assessed at each clinic visit (the frequency depending on physician’s discretion), with evaluation of organ damage (at least annually), using validated instruments. C. Non- pharmacological interventions, including…
2023 EULAR recommendations for the management of systemic lupus erythematosus
Non-Renal Systemic Lupus Erythematosus Figure 1 Treatment of non- renal systemic lupus erythematosus. Fanouriakis A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis Epub doi:10.1136/ard-2023 224762 Top- to bottom sequence does not imply order of preference (eg, MTX, AZA and MMF are equal options for second- line therapy in mild…
Treat to target (T2T) guidelines for Psoriatic arthritis
Algorithm based on the 2017 update of the treat-to-target recommendations for spondyloarthritis. axSpA, axial SpA; CRP, C-reactive protein; DAPSA, Disease Activity index for PSoriatic Arthritis; MDA, Minimal Disease Activity; PsA, psoriatic arthritis; SpA, spondyloarthritis. Source: Smolen JS, Schöls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international…
2023 EULAR recommendations algorithm for the management of Psoriatic Arthritis (PsA)
Source: Gossec, Laure et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases, Volume 83, Issue 6, 706 – 719
2022 EULAR recommendations for the management of rheumatoid arthritis
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Source: Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management ofrheumatoid arthritis with synthetic and biological disease- modifying antirheumatic drugs: 2022 update. Ann Rheum Dis Epub. Accessed on 28/06/025. doi:10.1136/ard-2022 223356
Overarching principles of treating Rheumatoid Arthritis to target
Overarching principles 10 recommendations on treating rheumatoid arthritis to target based on both evidence and expert opinion:
Rheumatology TT 